Cargando…
P063: Trial in Progress: Individualized Immunotherapy in Early-Stage Unfavorable Hodgkin Lymphoma - The Investigator-Initiated Phase II GHSG INDIE Trial
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621519/ http://dx.doi.org/10.1097/01.HS9.0000890820.12468.10 |
| _version_ | 1784821575457964032 |
|---|---|
| author | Bröckelmann, Paul J. Kaul, Helen Fuchs, Michael Kobe, Carsten Baues, Christian Borchmann, Peter Engert, Andreas |
| author_facet | Bröckelmann, Paul J. Kaul, Helen Fuchs, Michael Kobe, Carsten Baues, Christian Borchmann, Peter Engert, Andreas |
| author_sort | Bröckelmann, Paul J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9621519 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96215192022-11-01 P063: Trial in Progress: Individualized Immunotherapy in Early-Stage Unfavorable Hodgkin Lymphoma - The Investigator-Initiated Phase II GHSG INDIE Trial Bröckelmann, Paul J. Kaul, Helen Fuchs, Michael Kobe, Carsten Baues, Christian Borchmann, Peter Engert, Andreas Hemasphere Immunotherapy Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621519/ http://dx.doi.org/10.1097/01.HS9.0000890820.12468.10 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Immunotherapy Bröckelmann, Paul J. Kaul, Helen Fuchs, Michael Kobe, Carsten Baues, Christian Borchmann, Peter Engert, Andreas P063: Trial in Progress: Individualized Immunotherapy in Early-Stage Unfavorable Hodgkin Lymphoma - The Investigator-Initiated Phase II GHSG INDIE Trial |
| title | P063: Trial in Progress: Individualized Immunotherapy in Early-Stage Unfavorable Hodgkin Lymphoma - The Investigator-Initiated Phase II GHSG INDIE Trial |
| title_full | P063: Trial in Progress: Individualized Immunotherapy in Early-Stage Unfavorable Hodgkin Lymphoma - The Investigator-Initiated Phase II GHSG INDIE Trial |
| title_fullStr | P063: Trial in Progress: Individualized Immunotherapy in Early-Stage Unfavorable Hodgkin Lymphoma - The Investigator-Initiated Phase II GHSG INDIE Trial |
| title_full_unstemmed | P063: Trial in Progress: Individualized Immunotherapy in Early-Stage Unfavorable Hodgkin Lymphoma - The Investigator-Initiated Phase II GHSG INDIE Trial |
| title_short | P063: Trial in Progress: Individualized Immunotherapy in Early-Stage Unfavorable Hodgkin Lymphoma - The Investigator-Initiated Phase II GHSG INDIE Trial |
| title_sort | p063: trial in progress: individualized immunotherapy in early-stage unfavorable hodgkin lymphoma - the investigator-initiated phase ii ghsg indie trial |
| topic | Immunotherapy |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621519/ http://dx.doi.org/10.1097/01.HS9.0000890820.12468.10 |
| work_keys_str_mv | AT brockelmannpaulj p063trialinprogressindividualizedimmunotherapyinearlystageunfavorablehodgkinlymphomatheinvestigatorinitiatedphaseiighsgindietrial AT kaulhelen p063trialinprogressindividualizedimmunotherapyinearlystageunfavorablehodgkinlymphomatheinvestigatorinitiatedphaseiighsgindietrial AT fuchsmichael p063trialinprogressindividualizedimmunotherapyinearlystageunfavorablehodgkinlymphomatheinvestigatorinitiatedphaseiighsgindietrial AT kobecarsten p063trialinprogressindividualizedimmunotherapyinearlystageunfavorablehodgkinlymphomatheinvestigatorinitiatedphaseiighsgindietrial AT baueschristian p063trialinprogressindividualizedimmunotherapyinearlystageunfavorablehodgkinlymphomatheinvestigatorinitiatedphaseiighsgindietrial AT borchmannpeter p063trialinprogressindividualizedimmunotherapyinearlystageunfavorablehodgkinlymphomatheinvestigatorinitiatedphaseiighsgindietrial AT engertandreas p063trialinprogressindividualizedimmunotherapyinearlystageunfavorablehodgkinlymphomatheinvestigatorinitiatedphaseiighsgindietrial |